Literature DB >> 15958092

Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases.

I Mayringer1, B Timeltaler, F Deisenhammer.   

Abstract

Intrathecal immunoglobulin synthesis can be assessed by different approaches. It can be measured quantitatively by the IgG index or qualitatively by isoelectric focusing (IEF) to detect oligoclonal bands (OCB). In this study we investigated if there is a correlation between the frequency of OCB and the IgG index and if the IgG index predicts the diagnosis of a demyelinating CNS disease (DMD). We found a positive correlation between the IgG index and the frequency of OCB as well as the probability of DMD. We conclude that quantitative assessment of CSF-IgG can be useful because it is easier and quicker to perform than IEF but cannot replace IEF in general because this is the most sensitive method to detect abnormal IgG in CSF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958092     DOI: 10.1111/j.1468-1331.2005.00997.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Authors:  An Goris; Ine Pauwels; Marte W Gustavsen; Brechtje van Son; Kelly Hilven; Steffan D Bos; Elisabeth Gulowsen Celius; Pål Berg-Hansen; Jan Aarseth; Kjell-Morten Myhr; Sandra D'Alfonso; Nadia Barizzone; Maurizio A Leone; Filippo Martinelli Boneschi; Melissa Sorosina; Giuseppe Liberatore; Ingrid Kockum; Tomas Olsson; Jan Hillert; Lars Alfredsson; Sahl Khalid Bedri; Bernhard Hemmer; Dorothea Buck; Achim Berthele; Benjamin Knier; Viola Biberacher; Vincent van Pesch; Christian Sindic; Annette Bang Oturai; Helle Bach Søndergaard; Finn Sellebjerg; Poul Erik H Jensen; Manuel Comabella; Xavier Montalban; Jennifer Pérez-Boza; Sunny Malhotra; Jeannette Lechner-Scott; Simon Broadley; Mark Slee; Bruce Taylor; Allan G Kermode; Pierre-Antoine Gourraud; Stephen J Sawcer; Bettina Kullle Andreassen; Bénédicte Dubois; Hanne F Harbo
Journal:  Brain       Date:  2015-01-22       Impact factor: 13.501

2.  No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Authors:  Madlyne Becker; Clotilde Latarche; Emilie Roman; Marc Debouverie; Catherine Malaplate-Armand; Francis Guillemin
Journal:  BMC Neurol       Date:  2015-05-13       Impact factor: 2.474

3.  Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis.

Authors:  Gabriella Passerini; Gloria Dalla Costa; Francesca Sangalli; Lucia Moiola; Bruno Colombo; Massimo Locatelli; Giancarlo Comi; Roberto Furlan; Vittorio Martinelli
Journal:  Mult Scler Int       Date:  2016-12-28

4.  Diagnostics of autoimmune neurodegeneration using fluorescent probing.

Authors:  Yakov Lomakin; Anna Kudriaeva; Nikita Kostin; Stanislav Terekhov; Alena Kaminskaya; Alexander Chernov; Maria Zakharova; Maria Ivanova; Taras Simaniv; Georgy Telegin; Alexander Gabibov; Alexey Belogurov
Journal:  Sci Rep       Date:  2018-08-23       Impact factor: 4.379

Review 5.  The Cerebrospinal Fluid in Multiple Sclerosis.

Authors:  Florian Deisenhammer; Henrik Zetterberg; Brit Fitzner; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

6.  The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  Cecilia Smith Simonsen; Heidi Øyen Flemmen; Trine Lauritzen; Pål Berg-Hansen; Stine Marit Moen; Elisabeth Gulowsen Celius
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-01-22

7.  IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis.

Authors:  Yang Zheng; Meng-Ting Cai; Fan Yang; Ji-Ping Zhou; Wei Fang; Chun-Hong Shen; Yin-Xi Zhang; Mei-Ping Ding
Journal:  Front Immunol       Date:  2020-08-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.